Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Hear Res. 2020 Aug 20;396:108039. doi: 10.1016/j.heares.2020.108039

Fig 4.

Fig 4.

Cochlear phenotype in Etv4/5 compound mutants. (Upper panel) Whole mount cochlea from P0 Etv4 KO (Etv4−/−; Etv5fl/+;Twist2Cre/+), Etv5 cKO (Etv4−/+;Etv5fl/fl;Twist2Cre/+), Etv4/5 compound mutant (Etv4−/−;Etv5fl/fl;Twist2Cre/+) and littermate control (Etv4−/+;Etv5fl/+;Twist2Cre/+) showing whole cochlea stained with Myosin 6 antibody (green). White arrowheads mark the beginning and the end of the cochlear length measurement. (Lower panel) Quantification of cochlear duct length at P0 from each mouse model relative to control. Scale bar=200μm.